Pritor� And Kinzalmono� As Protective As Current Gold Standard Cardiovascular Therapy But Offers Greater Tolerability The results of the landmark ONTARGET� trial, which were presented at the 57th Annual Scientific Sessions of the American College of Cardiology (ACC) in Chicago, prove that telmisartan, the modern angiotensin II receptor blocker (ARB), is as protective as ramipril, the current gold standard, in re
Source: www.medicalnewstoday.comClinical Trial Participants Not Deterred By Knowledge Of Doctor's Financial Interests A patient's willingness to participate in a clinical trial may be unaffected by the disclosure of a researcher's financial interests in the study, unless the amount of money a researcher stands to earn depends on the results of the trial, according to a new study by researchers at the Duke Clinical R
Source: www.medicalnewstoday.comHealth Benefits Discovered In Natural Trans Fats, University Of Alberta Study Shows Contrary to popular opinion, not all trans fats are bad for you.
Source: www.medicalnewstoday.comThe Analysis Of Frontal Lobe Microstructure May Provide Insight Into The Biological Causes Of Autism Autism Speaks, the nation's largest autism advocacy organization along with the Allen Institute for Brain Science and one of the country's leading autism researchers will join forces on a new research grant that will examine the architecture of the autistic brain. Led by Eric Courchesne, Ph.D.
Source: www.medicalnewstoday.comGender Bias On Anger Whether you are running for president or looking for a clerical job, you cannot afford to get angry if you are a woman, Yale University psychologist Victoria Brescoll has found.
Source: www.medicalnewstoday.comGenetic Reprogramming To radiation, chemotherapy, surgery and biological therapies deployed to wage war on cancer, M. D. Anderson researchers have added a new approach diplomacy."In this instance, we're not trying to kill cancer cells, rather we talk to cells and remind them of their regular programming. We persuade them to return to their normal behavior," says Jean-Pierre Issa, M.D., professor in M. D.
Source: www.medicalnewstoday.com
# posted by Network @ 9:00 PM
